$95.00
CJC-1295 (no DAC) and Ipamorelin is a research peptide blend combining two mechanistically distinct secretagogues that act synergistically on the growth hormone axis. CJC-1295 (Mod GRF 1–29) targets GHRH receptors, stimulating cAMP/PKA-mediated GH synthesis, while Ipamorelin binds the ghrelin receptor (GHS-R1a), activating Gq/11-linked calcium signaling pathways. Together, they serve as a model for studying peptide-induced GH pulsatility, receptor cross-talk, and hypothalamic–pituitary regulation in controlled experimental systems.
For research use only. Not for human consumption.
Research Applications
Dual-receptor signaling analysis via GHRHR and GHSR-1a
Pulsatile endocrine signaling and receptor cross-talk studies
cAMP- and Ca2+-dependent second messenger pathway evaluation
Downstream IGF-axis modulation in preclinical models
⚠️ Important Warnings and Disclaimers
Product Guidelines
Product intended for experimental and research purposes only.
Do not use without proper technical knowledge.
Keep refrigerated as per storage guidelines.
Results may vary based on genetics, diet, and lifestyle.
Keep out of reach of children.
Store according to technical instructions.
Do not reuse vials or materials.
Do not purchase if you have any doubts regarding its use.
Limitation of Liability The company is not responsible for:
Misuse or incorrect administration.
Adverse reactions or interactions with other medications.
Consequences resulting from self-medication.
The buyer assumes full responsibility for all risks associated with handling and utilization.
📌 Legal Compliance This product is marketed as a research chemical, in compliance with international laboratory supply practices. The sale of this product does not constitute an offer for medical treatment.